FDA acting commissioner to deliver keynote speech at AAM’s virtual conference
Janet Woodcock will share the latest FDA actions on quality initiatives, supply chain integrity, inspections during COVID-19, GDUFA III and BsUFA III, and innovation in the generic and biosimilars industry.